Morgan Stanley initiated coverage on Absci Corporation with a new price target

7/3/24 7:24:12 AM ET

Biotechnology: Commercial Physical & Biological Resarch

Health Care

Morgan Stanley initiated coverage of Absci Corporation with a rating of Overweight and set a new price target of $7.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ABSI

Date	Price Target	Rating	Analyst
1/22/2025	$9.00	Buy	Needham
10/2/2024	$10.00	Buy	Guggenheim
7/3/2024	$7.00	Overweight	Morgan Stanley
3/14/2024	$13.00	Sector Outperform	Scotiabank
12/5/2023	$3.00	Overweight	KeyBanc Capital Markets
5/4/2023	$4.00	Buy	H.C. Wainwright
8/12/2022		Overweight → Underweight	JP Morgan
7/18/2022	$8.00	Buy	Truist